ACS medicinal chemistry letters - JoVE Visualize

Showing results (1191-1200 of 4,380) with videos related to

Pageof 438

Sort By:

ACS Medicinal Chemistry Letters|January 29, 2016

Anti-Staphylococcal Biofilm Effects of Human Cathelicidin PeptidesBiswajit Mishra, Radha M Golla, Kyle Lau, et al.

ACS Medicinal Chemistry Letters|November 20, 2014

1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 BromodomainEmmanuel H Demont, Paul Bamborough, Chun-Wa Chung, et al.

ACS Medicinal Chemistry Letters|November 20, 2014

Enantiopure Cyclopropane-Bearing Pyridyldiazabicyclo[3.3.0]octanes as Selective α4β2-nAChR LigandsOluseye K Onajole, J Brek Eaton, Ronald J Lukas, et al.

ACS Medicinal Chemistry Letters|November 20, 2014

Dihydropyrrolo[2,3-d]pyrimidines: Selective Toll-Like Receptor 9 Antagonists from Scaffold Morphing EffortsManabu Watanabe, Mai Kasai, Hideyuki Tomizawa, et al.

ACS Medicinal Chemistry Letters|October 22, 2015

Synthesis and Biological Evaluation of Polar Functionalities Containing Nitrodihydroimidazooxazoles as Anti-TB AgentsKushalava Reddy Yempalla, Gurunadham Munagala, Samsher Singh, et al.

ACS Medicinal Chemistry Letters|October 22, 2015

Inhibition of Invasion in Pancreatic Cancer Cells by Conjugate of EPA with β(3,3)-Pip-OH via PI3K/Akt/NF-kB PathwayHina Amin, Naiem Ahmad Wani, Saleem Farooq, et al.

ACS Medicinal Chemistry Letters|October 22, 2015

Potent Inhibitors Active against HIV Reverse Transcriptase with K101P, a Mutation Conferring Rilpivirine ResistanceWilliam T Gray, Kathleen M Frey, Sarah B Laskey, et al.

ACS Medicinal Chemistry Letters|October 22, 2015

Synthesis and Evaluation of Novel Erlotinib-NSAID Conjugates as More Comprehensive Anticancer AgentsYanmei Zhang, Micky D Tortorella, Jinxi Liao, et al.

ACS Medicinal Chemistry Letters|April 21, 2016

Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided DesignJason B Cross, Jing Zhang, Qingyi Yang, et al.

ACS Medicinal Chemistry Letters|April 21, 2016

Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, with Improved Potency, Safety, and PermeabilityWilliam A Kinney, Mark E McDonnell, Hua Marlon Zhong, et al.

Pageof 438

Showing results (1191-1200 of 4,380) with videos related to

Sort By:

Pageof 438

ACS Medicinal Chemistry Letters|January 29, 2016

Anti-Staphylococcal Biofilm Effects of Human Cathelicidin PeptidesBiswajit Mishra, Radha M Golla, Kyle Lau, et al.

ACS Medicinal Chemistry Letters|November 20, 2014

1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 BromodomainEmmanuel H Demont, Paul Bamborough, Chun-Wa Chung, et al.

ACS Medicinal Chemistry Letters|November 20, 2014

Enantiopure Cyclopropane-Bearing Pyridyldiazabicyclo[3.3.0]octanes as Selective α4β2-nAChR LigandsOluseye K Onajole, J Brek Eaton, Ronald J Lukas, et al.

ACS Medicinal Chemistry Letters|November 20, 2014

Dihydropyrrolo[2,3-d]pyrimidines: Selective Toll-Like Receptor 9 Antagonists from Scaffold Morphing EffortsManabu Watanabe, Mai Kasai, Hideyuki Tomizawa, et al.

ACS Medicinal Chemistry Letters|October 22, 2015

Synthesis and Biological Evaluation of Polar Functionalities Containing Nitrodihydroimidazooxazoles as Anti-TB AgentsKushalava Reddy Yempalla, Gurunadham Munagala, Samsher Singh, et al.

ACS Medicinal Chemistry Letters|October 22, 2015

Inhibition of Invasion in Pancreatic Cancer Cells by Conjugate of EPA with β(3,3)-Pip-OH via PI3K/Akt/NF-kB PathwayHina Amin, Naiem Ahmad Wani, Saleem Farooq, et al.

ACS Medicinal Chemistry Letters|October 22, 2015

Potent Inhibitors Active against HIV Reverse Transcriptase with K101P, a Mutation Conferring Rilpivirine ResistanceWilliam T Gray, Kathleen M Frey, Sarah B Laskey, et al.

ACS Medicinal Chemistry Letters|October 22, 2015

Synthesis and Evaluation of Novel Erlotinib-NSAID Conjugates as More Comprehensive Anticancer AgentsYanmei Zhang, Micky D Tortorella, Jinxi Liao, et al.

ACS Medicinal Chemistry Letters|April 21, 2016

Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided DesignJason B Cross, Jing Zhang, Qingyi Yang, et al.

ACS Medicinal Chemistry Letters|April 21, 2016

Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, with Improved Potency, Safety, and PermeabilityWilliam A Kinney, Mark E McDonnell, Hua Marlon Zhong, et al.

Pageof 438